Intralesional injections of a genetically modified adenovirus carrying human genes which code for gamma interferon are showing promise as a treatment for multiple BCCs. Dermatologist and principal investigator Dr Greg Siller, from Central Brisbane Dermatology, leads a phase 2 study of the adenovirus combined with the hedgehog pathway inhibitor vismodegib. Dr Siller told the limbic ...
Australian dermatologists use ‘Trojan horse’ virus to deliver interferon within BCCs
By Mardi Chapman
28 Oct 2020